Toujeo

Another “new” insulin for Australia

In April there was big news as Sanofi’s long-acting Toujeo U300 insulin was added to the Pharmaceutical Benefits Scheme (PBS) and thus became accessible to many people. It had received TGA approval some time beforehand and was available under private prescription, but the cost was significant.┬áBut at the time I failed to mention another new …

Another “new” insulin for AustraliaRead More »